Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
AIDS Research and Human Retroviruses|May 1, 2012
Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trialC William Wester, Svetlana K Eden, Bryan E Shepherd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Journal of Clinical Microbiology|April 19, 2003
Accuracy of the TRUGENE HIV-1 genotyping kitRobert M Grant, Daniel R Kuritzkes, Victoria A Johnson, et al.
Scientific Reports|July 19, 2022
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological studyAmelia Sancilio, Joshua M Schrock, Alexis R Demonbreun, et al.
Chembiochem : a European Journal of Chemical Biology|October 22, 2019
Differential Inhibition of APOBEC3 DNA-Mutator Isozymes by Fluoro- and Non-Fluoro-Substituted 2'-Deoxyzebularine Embedded in Single-Stranded DNAMaksim V Kvach, Fareeda M Barzak, Stefan Harjes, et al.
Bulletin of the World Health Organization|January 15, 2009
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretroviralsMacarthur Charles, Francine Noel, Paul Leger, et al.
The Journal of Infectious Diseases|November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group StudyDavid W Haas, Laura M Smeaton, Robert W Shafer, et al.
JCI Insight|March 23, 2021
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposureAlexis R Demonbreun, Thomas W McDade, Lorenzo Pesce, et al.
Pharmacogenetics and Genomics|October 19, 2006
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group studyAlison A Motsinger, Marylyn D Ritchie, Robert W Shafer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposureAlexis R Demonbreun, Thomas W McDade, Lorenzo Pesce, et al.
Pageof 8